These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27364506)

  • 61. Decreasing contralateral prophylactic mastectomy rates in average-risk women with unilateral breast cancer.
    Kapur H; Warburton R; Pao JS; Dingee C; Chen L; McKevitt E
    Am J Surg; 2021 Jun; 221(6):1172-1176. PubMed ID: 33795126
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
    Tercyak KP; Peshkin BN; Brogan BM; DeMarco T; Pennanen MF; Willey SC; Magnant CM; Rogers S; Isaacs C; Schwartz MD
    J Clin Oncol; 2007 Jan; 25(3):285-91. PubMed ID: 17159191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    ElSherif A; Armanyous S; Gentle CK; Al-Hilli Z; Valente SA
    Am J Surg; 2022 Mar; 223(3):533-537. PubMed ID: 34924172
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in
    Makhnoon S; Gutierrez Barrera AM; Bassett R; Afrough A; Bedrosian I; Arun BK
    Breast J; 2022; 2022():1447545. PubMed ID: 36685664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
    Mamtani A; Sjoberg DD; Vincent A; Ehdaie B; Malhotra D; Vickers A; Morrow M
    Breast Cancer Res Treat; 2023 May; 199(1):119-126. PubMed ID: 36881270
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
    Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
    Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
    Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
    Yoshimura A; Okumura S; Sawaki M; Hattori M; Ishiguro J; Adachi Y; Kotani H; Gondo N; Kataoka A; Iwase M; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Takaiso N; Hyodo I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):539-546. PubMed ID: 29520501
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Indications for Contralateral Prophylactic Mastectomy: A Consensus Statement Using Modified Delphi Methodology.
    Wright FC; Look Hong NJ; Quan ML; Beyfuss K; Temple S; Covelli A; Baxter N; Gagliardi AR
    Ann Surg; 2018 Feb; 267(2):271-279. PubMed ID: 28594745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Trends in Contralateral Prophylactic Mastectomy and Other Types of Breast Cancer Surgery, South Carolina, 2005-2013.
    Clerville J; Bolick S; Clugstone S
    J Registry Manag; 2018; 45(1):28-32. PubMed ID: 30183694
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Contralateral prophylactic mastectomy in a rural population: A single-institution experience.
    Clegg DJ; Whiteaker EN; Salomon BJ; Gee KN; Porter CG; Mazonas TW; Heidel RE; Brooks AJ; Bell JL; Boukovalas S; Lloyd JM
    Surg Open Sci; 2024 Mar; 18():70-77. PubMed ID: 38435489
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predicting women's intentions for contralateral prophylactic mastectomy: An application of an extended theory of planned behaviour.
    Richards I; Tesson S; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Eur J Oncol Nurs; 2016 Apr; 21():57-65. PubMed ID: 26952679
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
    J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction.
    Myers SP; Bayard S; Tadros AB; Sevilimedu V; Matros E; Nelson JA; Le T; Garcia P; Morrow M; Lee MK
    Ann Surg Oncol; 2024 Feb; 31(2):966-973. PubMed ID: 37973646
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The use of contralateral prophylactic mastectomy among elderly patients in the United States.
    Marmor S; Altman AM; Mayleben WT; Hui JYC; Denbo JW; Jensen EH; Tuttle TM
    Breast Cancer Res Treat; 2019 Aug; 177(1):175-183. PubMed ID: 31140081
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
    Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
    Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: a report from the National Cancer Data Base.
    Pesce CE; Liederbach E; Czechura T; Winchester DJ; Yao K
    J Am Coll Surg; 2014 Jul; 219(1):19-28. PubMed ID: 24862886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.